Adar Poonawalla CEO of Serum Institute of India SII the world s biggest vaccine maker speaks during an interview with Reuters in the Alpine resort of Davos Switzerland May NEW DELHI Sept Reuters The Serum Institute of India SII the world s biggest vaccine maker has developed the country s first cervical cancer shot that will hit the market soon the company and the government said on Thursday Cervical cancer is the fourth most common cancer among women globally with an estimated new cases and deaths in according to the World Health Organization About of the new cases and deaths worldwide occurred in low and middle income countries that year Two human papillomavirus HPV types and are responsible for at least of cervical cancers and India s Department of Biotechnology said the Indian vaccine would work on HPV types and as well as and The indigenously developed vaccine will make our country self sufficient in curbing female mortality caused by cervical cancer SII Chief Executive Adar Poonawalla said in a statement He told reporters the vaccine would be out for sale in a few months first for the Indian market and then the world It may be priced between rupees and rupees and the company will aim to produce about million doses in two years Reuters partner ANI cited Poonawalla as saying The vaccine will be administered via injection in two doses among year olds and in three doses for those between and Read more 